Cargando…
Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040236/ https://www.ncbi.nlm.nih.gov/pubmed/33845777 http://dx.doi.org/10.1186/s12879-021-06016-8 |
| _version_ | 1783677747186368512 |
|---|---|
| author | Nickel, Katharina Halfpenny, Nicholas J. A. Snedecor, Sonya J. Punekar, Yogesh Suresh |
| author_facet | Nickel, Katharina Halfpenny, Nicholas J. A. Snedecor, Sonya J. Punekar, Yogesh Suresh |
| author_sort | Nickel, Katharina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8040236 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80402362021-04-12 Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis Nickel, Katharina Halfpenny, Nicholas J. A. Snedecor, Sonya J. Punekar, Yogesh Suresh BMC Infect Dis Correction BioMed Central 2021-04-12 /pmc/articles/PMC8040236/ /pubmed/33845777 http://dx.doi.org/10.1186/s12879-021-06016-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Nickel, Katharina Halfpenny, Nicholas J. A. Snedecor, Sonya J. Punekar, Yogesh Suresh Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis |
| title | Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis |
| title_full | Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis |
| title_fullStr | Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis |
| title_full_unstemmed | Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis |
| title_short | Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis |
| title_sort | correction to: comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with hiv-1: an update on a systematic review and network meta-analysis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040236/ https://www.ncbi.nlm.nih.gov/pubmed/33845777 http://dx.doi.org/10.1186/s12879-021-06016-8 |
| work_keys_str_mv | AT nickelkatharina correctiontocomparativeefficacysafetyanddurabilityofdolutegravirrelativetocommoncoreagentsintreatmentnaivepatientsinfectedwithhiv1anupdateonasystematicreviewandnetworkmetaanalysis AT halfpennynicholasja correctiontocomparativeefficacysafetyanddurabilityofdolutegravirrelativetocommoncoreagentsintreatmentnaivepatientsinfectedwithhiv1anupdateonasystematicreviewandnetworkmetaanalysis AT snedecorsonyaj correctiontocomparativeefficacysafetyanddurabilityofdolutegravirrelativetocommoncoreagentsintreatmentnaivepatientsinfectedwithhiv1anupdateonasystematicreviewandnetworkmetaanalysis AT punekaryogeshsuresh correctiontocomparativeefficacysafetyanddurabilityofdolutegravirrelativetocommoncoreagentsintreatmentnaivepatientsinfectedwithhiv1anupdateonasystematicreviewandnetworkmetaanalysis |